Business ❯ Pharmaceutical Industry

Drug Pricing Strategies

Market Competition Market Impact Negotiations Market Dynamics Direct-to-Consumer Sales Market Analysis 340B Program Impact Direct to Consumer Sales AstraZeneca Medicare and Medicaid Consumer Pricing Medicare Drug Negotiations Negotiation Processes Medicaid Pricing Discount Programs Investment in Research Market Comparisons Market Regulations Market Comparison Government Programs Market Access International Pricing Government Regulations International Markets

Drug-Cost Anxiety Hits New High in KFF Poll as TrumpRx Sees Limited Reach

Democrats now lead on voter trust to address prescription prices.

Democratic Report Puts TrumpRx Under Fresh Scrutiny as Analyses Question Real-World Savings

Trump Cites 'Very Fat' Friend's Ozempic Story to Decry Price Gap

Medicare’s First Negotiated Drug Prices Take Effect Jan. 1, Cutting 2026 Costs

CMS Launches ‘Generous’ Pilot to Tie Medicaid Drug Prices to International Benchmarks

Senators Edge Toward 340B Overhaul as CBO Warns on Costs and HRSA Plans 2026 Rebate Pilot